A new study on insulin access for people living with diabetes projects that 40 million people with this disease They will stay without the vital medicine for the year 2030, particularly in regions of Africa, Asia and Oceania.
As the number of people living with diabetes continues to increase, el access to insulin necessary to satisfy the growing demand will be reduced, according to a research published in the Lancet Diabetes and Endocrinology magazine.
Diabetes, which can cause blindness, kidney failure, heart problems, neuropathic pain and amputations, currently affects 9% of adults around the world.
The researchers said that the insulin demand needed to effectively treat the Type 2 diabetes It will increase by more than 20% in the next 12 years, but that insulin will be out of reach of half of the 79 million diabetics of type 2 It is predicted that they will need it in 2030.
By 2030, it is expected that 79 million adults with type 2 diabetes they need insulin to control their condition and, if current levels of access are maintained, only half of them may obtain an adequate supply, the study funded by the Helmsley Charitable Trust revealed.
Access to the drug must be significantly improved, researchers warn, particularly in the regions of Africa, Asia and Oceania, which will be the most affected.
"These estimates suggest that current levels of insulin access are very inadequate compared to projected needs, particularly in Africa and Asia, and more efforts must be made to overcome this health challenge that is coming," said Sanjay Basu, Professor of Medicine in Stanford, who directed the investigation.
"Despite the commitment of the United Nations to treat non-transmissible diseases and guarantee universal access to diabetes medications, in most of the world insulin is scarce and difficult to access for patients, "he recalled.
Insulin is necessary to treat all people with type 1 diabetes and some people with type 2 diabetes. The development of 2 is strongly linked to lifestyle factors such as obesity, poor nutrition and physical inactivity.
The team of Basu was proposed explore how to change diabetes rates over the next 12 years, that is to say, how much the numbers will increase, to predict the amount of insulin that will be needed and if all those who need it will have access.
Using data from the International Federation of Diabetes and 14 studies to obtain an image of the numbers of type 2 diabetes in 221 countries, the team modeled the burden of type 2 diabetes from 2018 to 2030.
They predicted that, in the whole world, the number of adults with type 2 diabetes will increase from 406 million in 2018 to 511 million in 2030.
The United States will have the third highest in the world, with 32 million people expected to live with the disease in 2030.
"It is expected that the number of adults with type 2 diabetes will increase in the next 12 years due to aging, urbanization and changes associated with diet and physical activity," said Basu.
Insulin treatment is expensive and the market is currently dominated by three manufacturers, according to the study.
"Unless governments begin initiatives to make insulin available and affordable, then its use will always be far from optimum," he said.